End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.11 CNY | -0.42% | +2.30% | -11.90% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 59% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- The company appears to be poorly valued given its net asset value.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.90% | 833M | - | ||
+4.85% | 105B | A- | ||
-5.99% | 62.84B | A- | ||
+72.86% | 49.15B | B | ||
+15.33% | 38.45B | B | ||
+5.32% | 32.61B | A- | ||
+14.73% | 20.65B | B- | ||
+12.59% | 16.81B | C+ | ||
+18.15% | 15.14B | B- | ||
+3.29% | 14.14B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603113 Stock
- Ratings Jinneng Science&Technology Co.,Ltd